Navigation Links
U.S. Patent Office Allows Significant New VNUS Patent
Date:4/18/2008

elieve that the newly allowed claims further broaden our strong patent position and help to confirm that VNUS pioneered the key endovenous methods required to successfully treat venous reflux."

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (NASDAQ: VNUS) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that causes the varicose veins afflicting 25 million Americans. The pioneering company in the field, VNUS now offers the ClosureFAST system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. VNUS devices have been used in more than 300,000 procedures worldwide. For more information, please visit http://www.vnus.com.

FORWARD-LOOKING STATEMENTS

In addition to statements of historical facts or statements of current conditions, VNUS has made forward-looking statements in this press release. Actual results may differ materially from current expectations based on a number of factors outside VNUS's control, including possible future actions by the U.S. Patent & Trademark Office concerning the patent application discussed herein and future rulings in our pending patent litigation. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.

Additional information concerning these and other risk factors can be found in press releas
'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. The Quantum Group Files Four Additional Patents
2. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
3. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
4. Laser Energetics Files Patent Application for a New BrightStar(TM) Alexandrite Laser
5. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
6. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
7. The United States Patent and Trademark Office Grants TransUnion Patent for Healthcare Financing Method
8. SUNY researcher issued patent for virtual telemicroscope
9. Toms of Maine Introduces a Patent-Pending New Formula with the Launch of its Natural Clean & Gentle Care and Sensitive Care Toothpastes
10. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
11. Prize or patent? Innovative ideas for funding medical drug development and access
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...ll for routine exams, 60,000 Americans were infect...thDay News) -- Two years after U.S. health officia...3 to 64, such testing remains hit-and-miss, and th... new testing guidelines and better testing methods...urban Washington D.C. The meeting was designed to ...
(Date:11/20/2008)....H., Nov. 20 Emerson Ecologics, LL...rnational Distributors, Inc., also,known as TIDhe...tor of,vitamins and supplements to the profession...bination of Emerson and TIDhealth creates the lead...cts and services in the high-growth,professional ...
(Date:11/20/2008)... are often reluctant to undergo a routine but pain... be fatal. According to the American Cancer Societ...und in American men and women and kills about 50,0...elop colon cancer have no symptoms or family histo...ne and gastroenterology, at Tel Aviv University,s ...
(Date:11/20/2008)... , STAMFORD, Conn, Nov. 20 Pu...poration Limited, today announced that they have e...ity Pharmaceuticals, Inc. to advance the research,...discovery and early clinical programs in the areas...e alliance will focus on supporting Infinity,s pip...
Breaking Medicine News(10 mins):Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3Health News:Emerson Ecologics Announces Acquisition of TIDhealth 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 3Health News:A simple blood test for colon cancer 2Health News:Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain 2
...erers of osteoporosis, as well as, prevent potenti...ring the influence of dietary// supplements on ost...uiting post-menopausal women (aged 45 and above) t...one loss. According to Professor Helene McNulty, ...
...shaking research worldwide the leaders of the worl... out of their piggy banks to save// the poorest of... diving into a bleak era which seems to offer lit... to those who suffer from the same illness in high...
...grow old in good health should have strong grip, n...ding to a recent study.// A 40-year study of near...te of Hawaii revealed nine factors that were good ... men would live healthily into their 80s and beyon...
...at are based on a non-nucleoside reverse transcrip...s treatment with a protease inhibitor// but requir... to a new study funded in part by HHS’ Agency for ...study, published in the October 28 online issue of...
Other Medicine News:Health News:Poor diabetics: bitter times and worse times with no sweet respite 2Health News:Keys to Good Health in Old Age Begins in Midlife 2Health News:A More Convenient HIV Treatment Is as Effective as More Complex Regimens 2Health News:A More Convenient HIV Treatment Is as Effective as More Complex Regimens 3
(Date:11/20/2008)...-- The Scandinavian-based drug,development compan... on its,lead antimicrobial candidate LTX-109. Pre...owed that the novel lytic peptidomimetic has an ul...ter towards killing Staphylococcus,aureus and Str...ugs. In,addition to this it has proven effective ...
(Date:11/19/2008)...iotech scientists increasingly are applying genomi...nderstand the effects of novel drug candidates on ...eering & Biotechnology News ( GEN ). They are...und,s mechanism of action and eventually developin...the November 15 issue of GEN . ( http://www.genen...
(Date:11/18/2008)...on Medical Resources (AMR), a,provider of premier...agnostic,imaging industries, finds that over $10 ... U.S. during the third quarter of 2008. Privigen i... (IVIG) and was launched in the first,quarter of ...sma of thousands,of donors and is used to treat i...
(Date:11/13/2008)...s Prior to Surgery, ARLINGTON HEIGHTS, Ill., Nov....ition before surgery in massive weight loss patien...ease surgical complications, accelerate,wound heal... levels,according to a study in the December issu...ficial medical journal of the American Society of ...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2N J nurses are overworked according to Rutgers College of Nursing professor 6072 1N J nurses are overworked according to Rutgers College of Nursing professor 6072 2The key to unlocking the secret of highly specific DNAzyme catalysis 1182 1The key to unlocking the secret of highly specific DNAzyme catalysis 1182 2New genetic lineage of Ebola virus discovered in great apes 6070 1New genetic lineage of Ebola virus discovered in great apes 6070 2New genetic lineage of Ebola virus discovered in great apes 6070 3Repellents between dusk and bedtime make insecticide treated bednets more effective 6068 1Repellents between dusk and bedtime make insecticide treated bednets more effective 6068 2
...Professor Home said: , "The editorials published b...t they disregarded important pieces of data that,a...Most,significantly the editorials ignored data tha...ular death or death from any,cause." , Professor P...778-525-1736 , Terms and conditions of use apply ...
...ief within 5,minutes of dosing and is well-tolerat...arma Ltd,("Archimedes"), a European specialty phar...ata from a Phase II study of Nasalfent(r),an inno...ding a,fast, effective and convenient treatment fo... the 10th Congress of the European,Association for...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3
...an easy-to-use, hand-held instrument that provides...n tonometry. TONO-PEN AVIA has a lightweight, ergo...echnology that enables operators to take fast and ...ONO-PEN AVIA is powered by a long-life TONO-PEN AV...
...pipette Dispenser cover all volumes from 0.2 mL to...eproducibility, due to the careful design of all c...latest addition to the extensive Thermo Scientific...ring users reliability across all their dispensing...
...e (DUR-D) incorporates many of the patented featur...4; series flexible ureteroscopes. It is also the f...lds smallest, ultra-miniature 1 mm Complementary M...hnology that was developed and announced in 2005 a...
...rom innovative research in materials and technolog...erospace and automotive industry, the high- tech s...d textile industry. , ,This know-how has been tran...ollection to create unique and extremely innovativ...
Medicine Products: